Innoveren Scientific (Innoveren Scientific) Float Percentage Of Total Shares Outstanding : 57.20% (As of Jun. 04, 2024)

View and export this data going back to 2014. Start your Free Trial

What is Innoveren Scientific Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Innoveren Scientific's float shares is 0.41 Mil. Innoveren Scientific's total shares outstanding is 0.71 Mil. Innoveren Scientific's float percentage of total shares outstanding is 57.20%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Innoveren Scientific's Insider Ownership is 20.50%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Innoveren Scientific's Institutional Ownership is 0.05%.

Innoveren Scientific Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Innoveren Scientific's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding	=	Float Shares	/	Total Shares Outstanding
	=	0.41	/	0.71
	=	57.20%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innoveren Scientific (Innoveren Scientific) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Innoveren Scientific Inc (OTCPK:IVRN) » Definitions » Float Percentage Of Total Shares Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

2202 N West Shore Boulevard, Suite 200, Tampa, FL, USA, 33607

Website

https://www.hcyte.com

Innoveren Scientific Inc Formerly H-CYTE Inc is a hybrid biopharmaceutical company dedicated to developing and delivering new treatments for patients with chronic respiratory and pulmonary disorders. It has two divisions: the Healthcare Medical Biosciences Division (which includes the Infusion Vertical and the Biologics Vertical) and the DenerveX medical device division.

Executives

Fwhc Holdings, Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Hoa Capital Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Farrior J Rex Iii	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Fwhc Bridge Friends, Llc	10 percent owner	1306 W KENNEDY BOULEVARD, TAMPA FL 33606
Raymond Monteleone	director	201 E KENNEDY BLVD, STE 700, TAMPA FL 33602
Jeremy Daniel	officer: Chief Financial Officer	201 E KENNEDY AVE, STE 700, TAMPA FL 33602
Robert Smith Greif	officer: President and C.E.O.	19 MAY STREET, NEEDHAM MA 02492
Cfrs Investments, Llc	10 percent owner	2903 W VILLA ROSA PARK, TAMPA FL 33611
Frederick J Lynch	10 percent owner	C/O MASONITE INTERNATIONAL CORPORATION, 201 NORTH FRANKLIN ST., SUITE 300, TAMPA FL 33602
Fwhc Bridge, Llc	10 percent owner	334 EAST LAKE ROAD, SUITE 176, PALM HARBOT FL 34685
Todd R Wagner	10 percent owner	3385 OLD KEYSTONE ROAD, TARPON SPRINGS FL 34688
Michael Yurkowsky	director	2380 OLD MILTON PARKWAY, ALPHARETTA GA 30009
William E Horne	director, officer: Chief Executive Officer	201 EAST KENNEDY BLVD, SUITE 700, TAMPA FL 33602
Jon Mogford	director	714 PLUM HOLLOW DRIVE, COLLEGE STATION TX 77845
John C Thomas	director	8601 SIX FORKS ROAD, SUITE 160, RALEIGH NC 27615